Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ j24
ZUI\0qh+
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ])l[tVHm
p5rRhu/|k3
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
N~KRwsDH
%>U*A
1.Co-stimulators (or co-stimulating molecules) =}KbE4D+8
%hb5C 4q
2.NK-kB {!?RG\EYN
D}U<7=\3H
3.Immunoglobulin superfamily -Dm
.z16
1iW9?=a"
4.antigen-presenting cell (APC) (` Mz.VN
TRok4uc
5.death domain vaZZzv{H
=eLb"7C#0
6.CCR and CXCR 9o'6es..@Z
q,&T$Tw
7.Lectin (or mitogen) vp9<.*h
LkB!:+v |B
8.Clusters of differentiation, CD) (\>'yW{f
N+75wtLy&
9.B7 family loe>"_`Cq
elB
8
10.Cytotoxic T lymphocyte, CTL) ~`H<sJ?9
LTct0Gh
11.IL-15 and IL-15 receptor (IL-15R) 1U7HS2
@E;pT3; )
12.MHC restriction .Tv(1HAc2l
&Qjl|2
13.Affinity-chromatography \TlUC<urP
Y
sV
14.Cyctosprin A, CsA $SR]7GZ
c<e\JJY5?
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) &N0|tn
QovC
*1'
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© k;7.qhe:
):
C4}&l
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 -+_twU
UV.9KcN.
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ FG:BRS<m~
7!;/w;C
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ U^\~{X
qw1J{xoHW
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© w-Fk&dC69
EQC
ÃâÒßѧרҵ£º 7gcG|kKT
O]eJQ4XN<
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ J7o?h9
g<%-n,
Ïû»¯ÄÚ¿Æ£º )A=g#
D#
ypo=y/!
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ GJPZ[bo
c\MDOD%9
ѪҺ²¡Ñ§×¨Òµ£º 5&=n
vW3Zu B
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿